We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$16.1B
AUM Growth
+$2.04B
Cap. Flow
-$98.3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
35.04%
Holding
1,426
New
99
Increased
660
Reduced
349
Closed
106

Top Buys

Rank Stock Value
1
IRM icon
Iron Mountain
IRM
+$97M
2
VICI icon
VICI Properties
VICI
+$80.3M
3
ESS icon
Essex Property Trust
ESS
+$78.8M
4
WPC icon
W.P. Carey
WPC
+$61.7M
5
IBN icon
ICICI Bank
IBN
+$28M

Sector Composition

Rank Sector Weight
1 Real Estate 52.1%
2 Technology 13.53%
3 Consumer Discretionary 4.91%
4 Financials 4.82%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INBX
1176
DELISTED
Inhibrx, Inc. Common Stock
INBX
$7K ﹤0.01%
175
GPCR icon
1177
Structure Therapeutics
GPCR
$3.38B
$6K ﹤0.01%
+153
New +$8.77K
IRON icon
1178
Disc Medicine
IRON
$2.81B
$6K ﹤0.01%
+99
New +$5.07K
KYMR icon
1179
Kymera Therapeutics
KYMR
$8.61B
$6K ﹤0.01%
221
MYGN icon
1180
Myriad Genetics
MYGN
$485M
$6K ﹤0.01%
326
NVCR icon
1181
NovoCure
NVCR
$1.81B
$6K ﹤0.01%
422
PCRX icon
1182
Pacira BioSciences
PCRX
$1.05B
$6K ﹤0.01%
169
SUPN icon
1183
Supernus Pharmaceuticals
SUPN
$2.73B
$6K ﹤0.01%
217
AGIO icon
1184
Agios Pharmaceuticals
AGIO
$2.09B
$5K ﹤0.01%
204
APGE icon
1185
Apogee Therapeutics
APGE
$10.1B
$5K ﹤0.01%
+196
New +$3.93K
ARDX icon
1186
Ardelyx
ARDX
$1.24B
$5K ﹤0.01%
754
AUPH icon
1187
Aurinia Pharmaceuticals
AUPH
$1.91B
$5K ﹤0.01%
528
GMAB icon
1188
Genmab
GMAB
$17.6B
$5K ﹤0.01%
172
GRFS
1189
Grifois
GRFS
$5.61B
$5K ﹤0.01%
398
MRUS
1190
DELISTED
Merus
MRUS
$5K ﹤0.01%
186
RLAY icon
1191
Relay Therapeutics
RLAY
$3.96B
$5K ﹤0.01%
486
SAGE
1192
DELISTED
Sage Therapeutics
SAGE
$5K ﹤0.01%
239
SNDX icon
1193
Syndax Pharmaceuticals
SNDX
$1.69B
$5K ﹤0.01%
242
VIR icon
1194
Vir Biotechnology
VIR
$1.46B
$5K ﹤0.01%
535
VRNA
1195
DELISTED
Verona Pharma
VRNA
$5K ﹤0.01%
244
XNCR icon
1196
Xencor
XNCR
$1.47B
$5K ﹤0.01%
222
ZLAB icon
1197
Zai Lab
ZLAB
$2.06B
$5K ﹤0.01%
193
ALPN
1198
DELISTED
Alpine Immune Sciences Inc
ALPN
$5K ﹤0.01%
238
+153
+180% +$2.13K
ADMA icon
1199
ADMA Biologics
ADMA
$2B
$4K ﹤0.01%
791
AKRO
1200
DELISTED
Akero Therapeutics
AKRO
$4K ﹤0.01%
188

Similar funds

Daiwa Securities Group's Q4 2023 Portfolio in Review

As of Q4 2023, Daiwa Securities Group held 1,426 positions worth $16.1B, up 15% from $14B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group's Q4 2023 filing shows 99 new, 660 increased, 349 reduced and 106 closed positions. Its largest new stake was Veralto: 45,224 shares worth $3.72M. The largest sale was Mid-America Apartment Communities, an estimated $128M.

By sector, the portfolio is most concentrated in Real Estate at 52% of assets, down from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q4 2023 buy was Veralto: 45,224 shares worth $3.72M.
  • Daiwa Securities Group added most to Iron Mountain in Q4 2023, an estimated $97M increase.
  • Daiwa Securities Group's biggest Q4 2023 reduction was Mid-America Apartment Communities, cutting an estimated $128M.
  • Daiwa Securities Group fully exited Activision Blizzard in Q4 2023, selling an estimated $6.04M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $16.1B portfolio in Q4 2023.
  • Daiwa Securities Group opened 99 new positions and closed 106 in Q4 2023.
  • Daiwa Securities Group's portfolio value rose 15% quarter-over-quarter to $16.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.